Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,511 Anemia
clinical trials

Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Site
mi
from
Seat Pleasant, MD
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Takoma Park, MD
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tamarac, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tarzana, CA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Site
mi
from
Thomasville, NC
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Vidalia, GA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Cudahy, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Laurelton, NY
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
McAllen, TX
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Sumter, SC
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Yonkers, NY
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Status: Enrolling, Phase II
Updated: 4/30/2018
Montefiore Medical Center/Albert Einstein School of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
Indiana University Medical Center/ Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of Wisconsin/Midwest Children's Cancer
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Edgewater, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Roseville, MI
Click here to add this to my saved trials
Hemophilia A Clinical Trial
BAX 855 Previously Untreated Patient (PUP)
Status: Enrolling, Phase III
Updated: 4/19/2018
Ann & Robert H. Lurie Children's H
mi
from
Chicago, IL
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Hacienda Heights, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Mount Prospect, IL
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
New York-Presbyterian/Brooklyn Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
Foundation for Sickle Cell Research/Florida Sickle Inc.
mi
from
Hollywood, FL
Click here to add this to my saved trials
Hematology Clinical Trial
Longterm Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Hematology Clinical Trial
Longterm Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials
Hematology Clinical Trial
Longterm Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Cardiology Associates Of South Florida PA
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
New York-Presbyterian/Brooklyn Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Western Connecticut Health Network
mi
from
Danbury, CT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
North Ohio Heart Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Medicoricium, Llc
mi
from
Fairview Heights, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Vincent's Healthcare - Southside
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Angelina Medical Research, LLC
mi
from
Lufkin, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Joseph Heritage Healthcare
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
IMC Diagnostic and Medical Clinic
mi
from
Mobile, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Radin Cardiovascular Medical Group, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Chi Health Research Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Black Hills Cardiovascular Research, a department of Rapid City Regional Hospital, Inc.
mi
from
Rapid City, SD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan CardioVascular Institute at Covenant Medical Center
mi
from
Saginaw, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Maine Medical Partners Maine Health Cardiology
mi
from
Scarborough, ME
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Clinical Research/Intermountain Heart Center PC
mi
from
West Jordan, UT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Northtowns Cardiology, PLLC
mi
from
Williamsville, NY
Click here to add this to my saved trials
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Clinical Trial
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Clinical Trial
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Clinical Trial
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Clinical Trial
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Hematology Clinical Trial
Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis
Status: Enrolling, Phase II
Updated: 9/23/2017
UCSF Benioff Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Aplastic Anemia Clinical Trial
A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic Cleveland Clinic (5)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Aplastic Anemia Clinical Trial
A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Indiana University SC Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Regions Cancer Care Center
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Study of Emicizumab Prophylaxis in Participants With Hemophilia A and Inhibitors Undergoing Minor Surgical Procedures
Status: Enrolling, Phase IV
Updated: 12/31/1969
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence
Status: Enrolling, Phase II
Updated: 12/31/1969
CHRU de Brest - Hopital Morvan
mi
from
Brest Cedex,
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Hematology
mi
from
Chicago, IL
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Blood Research Institute at Blood Center of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
UC Davis Hemophilia Treatment Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Myocardial Ischemia and Transfusion
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Hospital at Gulfport
mi
from
Gulfport, MS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Myocardial Ischemia and Transfusion
Status: Enrolling, Phase III
Updated: 12/31/1969
Jersey Shore University Medical
mi
from
Neptune, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Myocardial Ischemia and Transfusion
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Langone Medical Center; Bellevue Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A Study of the Effect of IW-1701, a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Healthcare Research Network II, LLC
mi
from
Flossmoor, IL
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A Study of the Effect of IW-1701, a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Century Clinical Research, Inc.
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A Study of the Effect of IW-1701, a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Foundation for Sickle Cell Disease Research
mi
from
Hollywood, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
Status: Enrolling, Phase IV
Updated: 4/30/2018
Center for Outpatient Health, Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Miami Patient Treatment
mi
from
Miami, FL
Click here to add this to my saved trials
Anemia Clinical Trial
Study of INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS)
Status: Enrolling, Phase III
Updated: 12/31/1969
OneBlood
mi
from
Orlando, FL
Click here to add this to my saved trials
Warm Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD) Clinical Trial
Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD
Status: Enrolling, Phase II
Updated: 12/31/1969
New York Cancer and Blood Specialists
mi
from
Bronx, NY
Click here to add this to my saved trials
Warm Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD) Clinical Trial
Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD
Status: Enrolling, Phase II
Updated: 12/31/1969
Apellis Clinical Site
mi
from
Whittier, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
West Reading, PA
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Safety and Dose Escalation Study of an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia A Subjects
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hospital Universitario La Paz
mi
from
Madrid,
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Status: Enrolling, Phase II
Updated: 12/31/1969
UT Southwestern Medical Center; Pediatrics Dept.
mi
from
Dallas, TX
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Iron Deficiency Anemia Clinical Trial
Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA
Status: Enrolling, Phase III
Updated: 12/31/1969
Tekton Research, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions
Status: Enrolling, Phase III
Updated: 12/31/1969
HCA Midwest Health
mi
from
Kansas City, MO
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Boston Hemophilia Center at Children's Hospital of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Connecticut Bleeding and Clotting Disorders Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
UCSF Pediatric Hemophilia Treatment Center at Mission Bay
mi
from
San Francisco, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Florida Center for Pediatric Cellular Therapy
mi
from
Orlando, FL
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University/St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology Clinical Trial
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
Status: Enrolling
Updated: 8/8/2017
Pediatric Hematology Unit HaEmek Medical Center
mi
from
Afula,
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Sickle Cell Clinical Research and Intervention Program
Status: Enrolling, Phase
Updated: 12/31/1969
Novant Health Hemby Children's Hospital
mi
from
Charlotte, NC
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in Severe Sickle Cell Disease
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in Severe Sickle Cell Disease
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Cincinnati Medical Center/Research Office
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Royal Alexandra Hospital
mi
from
Edmonton,
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Hermann - TMC Investigational Drugs, IDS Pharmacy
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Louisville Physicians Pediatric Hematology Oncology
mi
from
Louisville, KY
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Department of Pediatric-Hematology-Oncology@
mi
from
Savannah, GA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Minnesota Physicians Bone Marrow Transplant Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
1 … 12 13 14 15 16 17 18 19 20 21 22 23 24 25